Celularity Inc.
CELU
$0.69
-$0.12-15.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -51.03% | -15.81% | 4.45% | 52.06% | 138.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -51.03% | -15.81% | 4.45% | 52.06% | 138.11% |
| Cost of Revenue | 33.92% | 16.16% | 17.96% | 7.99% | -6.41% |
| Gross Profit | -83.49% | -33.64% | -4.46% | 90.67% | 480.77% |
| SG&A Expenses | -12.58% | -6.10% | 3.45% | 16.20% | 15.95% |
| Depreciation & Amortization | -123.84% | -25.34% | -29.27% | -28.34% | -20.06% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.36% | 1.28% | 5.21% | 5.40% | -6.53% |
| Operating Income | -54.07% | -21.91% | -5.94% | 23.36% | 49.59% |
| Income Before Tax | -58.42% | -130.14% | 34.70% | 63.94% | 70.51% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -58.43% | -130.08% | 34.71% | 63.94% | 70.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.43% | -130.08% | 34.71% | 63.94% | 70.51% |
| EBIT | -54.07% | -21.91% | -5.94% | 23.36% | 49.59% |
| EBITDA | -71.77% | -30.94% | -11.16% | 24.72% | 54.39% |
| EPS Basic | -35.55% | -113.82% | 45.12% | 70.05% | 76.58% |
| Normalized Basic EPS | -26.44% | -133.87% | -121.93% | 7.91% | 49.81% |
| EPS Diluted | -35.55% | -113.82% | 45.12% | 70.05% | 76.58% |
| Normalized Diluted EPS | -26.44% | -133.87% | -121.93% | 7.91% | 49.81% |
| Average Basic Shares Outstanding | 16.90% | 13.89% | 12.92% | 16.25% | 22.95% |
| Average Diluted Shares Outstanding | 16.90% | 13.89% | 12.92% | 16.25% | 22.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |